Wistar Institute
The Wistar Institute is an independent nonprofit biomedical research institution. It is a global leader in oncology, immunology, infectious disease, and vaccine development. It is NCI‑designated and renowned for pioneering discoveries in cancer biology and successful vaccine advancements.
Address: 3601 Spruce Street, Philadelphia, PA 19104
Phone: (215) 898-3700
-
Wistar Institute, Temple Scientists Identify Metabolic Target To Overcome Chemotherapy Resistance in Ovarian Cancer
Many cancers can be treated by administering DNA-damaging agents, such as platinum-based chemotherapy, because the resulting DNA damage causes the cancer cells to die. A…
-
Researchers from Wistar Institute, ChristianaCare Identify Promising New Therapeutic Target for Pancreatic Cancer
Scientists at The Wistar Institute and clinical researchers from ChristianaCare’s Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could…
-
Wistar Institute Scientist Dr. Alex Price Awarded Prestigious, Early-Career NIH Grant
The Wistar Institute, a world leader in cancer, immunology, and infectious disease research, has been awarded a five-year, $2,532,750 National Institute of General Medical Sciences…
-
Wistar Institute Announces Recruitment of Murad Mamedov, Ph.D., to the Center for Advanced Therapeutics
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, has announced the appointment of Murad Mamedov, Ph.D., as assistant professor in…
-
Wistar Institute Welcomes James Lovett to Board of Trustees
The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome James Lovett to its Board of…
-
Wistar Scientists Develop Two-Vaccine Strategy to Fight T Cell Lymphoma
T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can’t easily distinguish cancerous…
-
Wistar Scientists Demonstrate First-Ever Single-Shot HIV Vaccine Neutralization Success
Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization…
-
The Wistar Institute Announces Dr. Dario Altieri Leadership Transition
The Wistar Institute, a biomedical research leader in cancer, immunology and infectious disease, announces Dario C. Altieri, M.D., Wistar’s president and CEO, director of the Ellen and…
-
Wistar Institute Announces the Recruitment of Jianliang Xu, Ph.D., to the HIV Cure and Viral Diseases Center
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, has announced the recruitment of Jianliang Xu, Ph.D., to Wistar’s HIV…
-
Wistar Institute’s New Center for Advanced Therapeutics Aims to Speed New Discoveries into New Medicines
In September 2025, The Wistar Institute announced the opening of its new Center for Advanced Therapeutics (CAT). The goal of the new center is to…
-
Wistar Institute Recruits Vincent Wu to Join Vaccine & Immunotherapy Center as Caspar Wistar Fellow
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased to announce the recruitment of Vincent Wu, Ph.D., to Wistar’s Vaccine…
-
Wistar Institute Receives $600,000 Grant to Support Biomedical Technician Training Pre-Apprenticeship
The Wistar Institute Hubert J.P. Schoemaker Education and Training Center can continue offering its signature Biomedical Technician Training (BTT) Pre-apprenticeship Program to bolster job opportunities in the life science sector…
-
LionCage Pitch Competition Awards $35,000 to Southeastern Pennsylvania Entrepreneurs
Invent Penn State LaunchBoxes at Brandywine and Great Valley and the Ideas x Innovation Network (i2n), an initiative of the Chester County Economic Development Council…
-
The Wistar Institute Appoints Two New Members to its Board of Trustees
The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome two new members to its Board…
-
First-in-Human Study of DNA Antibody Replicas Generate Efficient and Long-Lasting Biologic Production of Human Antiviral Antibodies
A multidisciplinary team of scientists led by The Wistar Institute, including Perelman School of Medicine at the University of Pennsylvania, AstraZeneca and Inovio Pharmaceuticals, published in Nature Medicine a breakthrough…
-
Wistar to Honor Dr. Svetlana Mojsov Whose Discovery of GLP-1 Protein is Behind Blockbuster Weight-Loss Drugs
The Wistar Institute honors Svetlana Mosjov, Ph.D., as the 2025 Helen Dean King Award recipient. Dr. Mojsov, research associate professor at the Rockefeller University, is…
-
Wistar Institute’s New iCure Consortium Aims to Develop Personalized HIV Treatment Strategies
A new five-year, $17 million research award has been used to fund and launch Wistar’s new iCure Consortium. The goal of the iCure Consortium is…
-
Wistar Scientists Discover p53 Can “Read” Cellular Signals to Direct Immune Response
Wistar Institute researchers have overturned three decades of scientific thinking about p53, the most important tumor suppressor protein in cancer research. In a study published…
Founding Partners
Advertisement
Affiliate Partners
